Zobrazeno 1 - 10
of 626
pro vyhledávání: '"Jarząb, P. P."'
Autor:
Anna Jarząb, Anna Dąbrowska, Piotr Naporowski, Karina Krasna, Agnieszka Szmyt, Michał Świat, Krzysztof Pawlik, Danuta Witkowska, Edmund Ziomek, Andrzej Gamian
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-11 (2024)
Abstract The anti-Shigella vaccine is one of the WHO’s top priorities. Every year the disease kills more than 200,000 people worldwide and poses a serious threat to children under 5 years of age and the elderly. Increasing antibiotic resistance and
Externí odkaz:
https://doaj.org/article/1c4063b9c97c42e78335c7ab2afcf16e
Autor:
Miroslawa Püsküllüoğlu, Małgorzata Pieniążek, Manuela Las-Jankowska, Joanna Streb, Marek Ziobro, Renata Pacholczak-Madej, Paulina Kilian-Van Miegem, Agnieszka Rudzińska, Aleksandra Grela-Wojewoda, Aleksandra Łacko, Michał Jarząb, Anna Polakiewicz-Gilowska
Publikováno v:
Oncology and Therapy, Vol 12, Iss 4, Pp 787-801 (2024)
Abstract Introduction Sacituzumab govitecan (SG) is approved for patients with previously treated metastatic or locally advanced triple-negative breast cancer (TNBC), as per the ASCENT trial results. Real-world studies (RWSs) cover more diverse patie
Externí odkaz:
https://doaj.org/article/a291db8f8f3349639563673c8304027e
Autor:
Szczepański Adrian, Klesiewicz Karolina, Ankiersztejn-Bartczak Magdalena, Olechowska-Jarząb Aldona, Brzychczy-Włoch Monika
Publikováno v:
Postępy Mikrobiologii, Vol 63, Iss 3, Pp 143-150 (2024)
Screening tests are now readily accessible, quick and highly sensitive. Diagnostics of HIV infections involves serological testing followed by confirmation tests by molecular biology methods (NAAT). Fast, accurate, anonymous and free HIV testing has
Externí odkaz:
https://doaj.org/article/c32b53a315614141a43fa47f8a82e613
Autor:
Marcin Kubeczko, Anna Polakiewicz-Gilowska, Andrea D’Amico, Olgierd Chrabański, Katarzyna Świderska, Ewa Chmielik, Sławomir Blamek, Daria Handkiewicz-Junak, Michał Jarząb
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
BackgroundCyclin-dependent kinase 4/6 (CDK4/6) inhibitors have demonstrated a survival benefit in the second-line treatment of patients with hormone receptor-positive human epidermal growth factor receptor 2-negative advanced breast cancer. However,
Externí odkaz:
https://doaj.org/article/9d9e1f7a93a64468bcf194119069923b
Autor:
Mirosława Püsküllüoğlu, Aleksandra Konieczna, Katarzyna Świderska, Joanna Streb, Małgorzata Pieniążek, Aleksandra Grela-Wojewoda, Renata Pacholczak-Madej, Anna Mucha-Małecka, Jerzy W. Mituś, Joanna Szpor, Michał Kunkiel, Agnieszka Rudzińska, Michał Jarząb, Marek Ziobro
Publikováno v:
Acta Oncologica, Vol 63, Iss 1 (2024)
Background and purpose: Metaplastic breast carcinoma (BC-Mp) is an uncommon subtype that poses unique challenges. The limited information on patient prognosis and therapeutic strategies motivated our research initiative. We aimed to assess disease-fr
Externí odkaz:
https://doaj.org/article/61f16568976e4d8daaf33a8feee12a11
Autor:
Marcin Kubeczko, Anna Polakiewicz-Gilowska, Katarzyna Świderska, Aleksandra Leśniak, Marta Mianowska-Malec, Barbarba Łanoszka, Konstanty Chomik, Barbara Grandys, Natalya Lisovska, Barbara Bobek-Billewicz, Ewa Chmielik, Michał Jarząb
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
BackgroundCyclin-dependent kinase 4/6 inhibitors (CDK4/6i) represent the gold standard of the hormone receptor positive human epidermal growth factor receptor 2 (HER-2) negative advanced breast cancer. However, optimal treatment after disease progres
Externí odkaz:
https://doaj.org/article/9a4c366505004ce28c0ef2c9cfb629a9
Autor:
Mateusz Tajstra, Maciej Dyrbuś, Tomasz Rutkowski, Krzysztof Składowski, Barbara Sosnowska‐Pasiarska, Stanisław Góźdź, Barbara Radecka, Marek Staszewski, Aleksandra Majsnerowska, Krzysztof Myrda, Alicja Nowowiejska‐Wiewióra, Ilona Skoczylas, Igor Rymkiewicz, Tomasz Niklewski, Jolanta Nowak, Piotr Przybyłowski, Mariusz Gąsior, Michał Jarząb
Publikováno v:
ESC Heart Failure, Vol 10, Iss 5, Pp 3174-3183 (2023)
Abstract Aims In recent years, survival in patients with breast cancer has increased. Despite the improvement in outcomes of those patients, the risk of treatment‐related cardiotoxicity remains high, and its presence has been associated with a high
Externí odkaz:
https://doaj.org/article/6b25ed90cf1646908a0d580d60baa77c
Autor:
Anna Żurawik, Tomasz Kasperski, Aldona Olechowska-Jarząb, Paulina Szczesiul-Paszkiewicz, Iwona Żak, Michał Wójcicki, Elżbieta Maćkiw, Agnieszka Chmielarczyk
Publikováno v:
Pathogens, Vol 13, Iss 9, p 725 (2024)
Listeriosis is one of the most serious foodborne diseases under surveillance, with an overall mortality rate in the EU currently being high at 18.1%. Therefore, this study aims to investigate Listeria monocytogenes strains isolated from clinical and
Externí odkaz:
https://doaj.org/article/aefe73b7ea7a4312a27cd5ceb71ffde3
Autor:
Marcin Kubeczko, Dorota Gabryś, Anna Polakiewicz-Gilowska, Barbara Bobek-Billewicz, Michał Jarząb
Publikováno v:
Pharmaceuticals, Vol 17, Iss 7, p 927 (2024)
Background. The use of locoregional radiotherapy (RT) in patients with advanced ER-positive, HER2-negative breast cancer remains a topic of ongoing debate. In this study, we aimed to evaluate the efficacy of locoregional RT in advanced breast cancer
Externí odkaz:
https://doaj.org/article/a6a356455bfc4010aa9722dfc8768f5e
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.